share_log
Breakings ·  Jul 2 20:00
Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 Cartitude-4 Trial in Multiple Myeloma
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment